Phosphorex
Biotechnology Research • 
Hopkinton, Massachusetts, United States • 11-20 Employees
Company overview
| Headquarters | 35 Parkwood Drive, Suite 210, Hopkinton, MA 01748, US |
| Phone number | +15084359100 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Drug Delivery, Pharma, Biotech, Nanoparticles, Cdmo, Targeted Drug Delivery, Controlled Release, Gene Delivery, Vaccine Development, Microspheres, Drug Release, Solubility Enhancement, Long Acting Injectables, Pnps, Lnps, Polymeric Nanoparticles, Oligonucleotide, Lipids Nano Particles, Formulation Of Nrnas & Dnas, Mrnas, Particle-Based Formulation |
| Founded | 2005 |
| Employees | 11-20 |
| Socials |
Key Contacts at Phosphorex
Jerry Williamson
Chief Executive Officer
Evan Turek
Business Development Director
Christian Renken
Director Of Business Development
Kim Yang
Marketing Director
Syed Reza
Member Board Of Directors
Nicholas Boylan
Senior Director, Scientific Services
Saher Abu Aita
Director Analytical Services
Phosphorex Email Formats
Phosphorex uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@phosphorex.com), used 82.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@phosphorex.com | 82.4% |
{first name}{last name} | johndoe@phosphorex.com | 17.6% |
About Phosphorex
Phosphorex provides drug delivery solutions to the pharmaceutical and biopharmaceutical industries, which include drug encapsulation, nanosizing, microemulsion, and surface functionalization and coating. Following is a brief summary of our expertise: • Microencapsulation/nanoencapsulation of small molecule active pharmaceutical ingredients (APIs) or biomolecules into biodegradable microspheres or nanoparticles enables controlled or sustained drug release, protecting APIs from premature degradation as well as increasing circulation time and targeted drug delivery. • Nanosizing can help you transform poorly soluble APIs with low bioavailability into nanocrystals that can be delivered more easily with enhanced solubility and bioavailability. • Microemulsion, in which a poorly soluble API is dissolved in oil and micro-emulsified into an aqueous media to form a homogeneous mix. • Surface functionalization and coating in which we attach a biological entity on the surface of drug loaded microspheres or nanoparticles via either covalent bonding or physical adsorption to enable cell entry, brain-blood barrier crossing, and targeted drug delivery. The services we provide apply to all stages of your drug development efforts. Whether you are testing a new idea, conducting animal studies, or moving to clinical studies, we can assist. With our fully integrated cGMP system, we can assure you that our processes are completely reproducible and scalable. Please visit www.phosphorex.com for more information.
Phosphorex revenue & valuation
| Annual revenue | $500,000 |
| Revenue per employee | $28,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Phosphorex has 6 employees across 3 departments.
Departments
Number of employees
Funding Data
Phosphorex has never raised funding before.
Phosphorex Tech Stack
Discover the technologies and tools that power Phosphorex's digital infrastructure, from frameworks to analytics platforms.
Miscellaneous
JavaScript libraries
Tag managers
Hosting
Operating systems
JavaScript libraries
Security
JavaScript libraries
SSL/TLS certificate authorities
Web servers
Marketing automation
UI frameworks
Germany
United Kingdom
Italy
South Africa
Spain
Frequently asked questions
4.8
40,000 users
